AKT1 and breast carcinoma: As in breast cancer, the use of specific or pan Akt inhibitors may not be sufficient or may even be detrimental as it might promote tumor invasiveness and cancer dissemination, protocols devised to increase the levels of Vav1 could be an option to improve breast cancer outcomes.